关注
Hyeji (Helena) Jun
Hyeji (Helena) Jun
Dana-Farber Cancer Institute
在 dfci.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Quantitative proteomics identifies TUBB6 as a biomarker of muscle‐invasion and poor prognosis in bladder cancer
B Kim, M Jung, KC Moon, D Han, K Kim, H Kim, S Yang, D Lee, H Jun, ...
International Journal of Cancer 152 (2), 320-330, 2023
142023
Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations
J Kim, K Jeong, H Jun, K Kim, JM Bae, MG Song, H Yi, S Park, G Woo, ...
Human Genomics 17 (1), 2, 2023
62023
Germline and somatic fumarate hydratase testing in atypical uterine leiomyomata
LM Kipnis, KM Breen, DR Koeller, AS Levine, Z Yang, H Jun, N Tayob, ...
Cancer Prevention Research 17 (5), 201-208, 2024
2024
Expression profiles of hypoxia-related genes of cancers originating from anatomically similar locations using TCGA database analysis
HL Bae, K Jeong, S Yang, H Jun, K Kim, YJ Chai
Medicines 11 (1), 2, 2023
2023
Abstract P5-03-20: Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations
J Kim, K Jeong, H Jun, K Kim, TY Kim, DW Lee, G Woo, S Park, H Yi, ...
Cancer Research 83 (5_Supplement), P5-03-20-P5-03-20, 2023
2023
Development of a transcriptome-based determination of innate immune suppressor (TDIS) assay as an in vitro test for immunotoxicity
H Quan, H Jun, K Kim, SK Lee, Y Heo, SH Seok, YR Na
Archives of Toxicology 97 (2), 495-507, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–6